Zinc-Alpha-2-Glycoprotein
AZGP1proteinAZGP1 promotes reverse cholesterol transport and suppresses inflammatory signaling, protecting against atherosclerotic lipid accumulation and plaque inflammation.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencehigh
RationaleRegulates reverse cholesterol transport and links inflammation to lipid homeostasis.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000160862
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(3)
- Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.Cardiovascular therapeutics · 2025 · PMID 40026415 · doi
- A comprehensive proteomic profiling of urinary exosomes and the identification of early non-invasive biomarker in patients with coronary artery disease.Journal of proteomics · 2023 · PMID 38151158 · doi
- Proteomic analysis detects deregulated reverse cholesterol transport in human subjects with ST-segment elevation myocardial infarction.Journal of proteomics · 2020 · PMID 32376501 · doi